ChemicalBook >> CAS DataBase List >>Pateclizumab

Pateclizumab

Pateclizumab structure

CAS No.: 1202526-59-7

Chemical Name:: Pateclizumab

Synonyms: Pateclizumab;Pateclizumab (anti-TNFb);Research Grade Pateclizumab

CBNumber:: CB78080841

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

MSDS File:: SDS

Last updated:2025-04-18 09:52:45

Request For Quotation

Pateclizumab Properties

form	Liquid
color	Colorless to light yellow
FDA UNII	QOK1YYH7J2

Pateclizumab price

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
ChemScene	CS-0900512	Pateclizumab ≥99.0%	1202526-59-7	1mg	$542	2026-06-04	Buy
ChemScene	CS-0900512	Pateclizumab ≥99.0%	1202526-59-7	5mg	$1625	2026-06-04	Buy
ChemScene	CS-0900512	Pateclizumab ≥99.0%	1202526-59-7	10mg	$2600	2026-06-04	Buy
aablocks	AA0294TM	Pateclizumab ≥95%(SDS-PAGE&SEC-HPLC)	1202526-59-7	1mg	$664	2026-06-02	Buy
aablocks	AA0294TM	Pateclizumab ≥95%(SDS-PAGE&SEC-HPLC)	1202526-59-7	5mg	$2000	2026-06-02	Buy

Product number	Packaging	Price	Buy
CS-0900512	1mg	$542	Buy
CS-0900512	5mg	$1625	Buy
CS-0900512	10mg	$2600	Buy
AA0294TM	1mg	$664	Buy
AA0294TM	5mg	$2000	Buy

Pateclizumab Chemical Properties,Uses,Production

Uses

Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1].

References

[1] Brinda Emu, et al. Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial. DOI:10.1186/ar3554

Pateclizumab Preparation Products And Raw materials

Raw materials

Preparation Products

Pateclizumab Suppliers

Global( 18)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	15026964105	2881489226@qq.com	China	89667	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	7998	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1577	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10305	58
TargetMol Chemicals Inc.	4008200310 15002144251	marketing@tsbiochem.com	China	24951	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9864	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7283	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11963	58
Wuhan Acumen Bio-Technology Co.,ltd	027-027-16602739303 16602739303	673003916@qq.com	China	4593	58
Changsha Fuzhen Biotechnology Co.，LTD	15111215862 18229892877	3062105966@qq.com	China	5549	58

Supplier	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	60
ShangHai Biochempartner Co.,Ltd	62
Guangzhou Hongyuan Chemical Co.,Ltd	58
Wuhan Chemstan Biotechnology Co., Ltd.	58
TargetMol Chemicals Inc.	58
Biolab Reagents	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Shanghai Yifei Biotechnology Co. , Ltd.	58
Wuhan Acumen Bio-Technology Co.,ltd	58
Changsha Fuzhen Biotechnology Co.，LTD	58

1202526-59-7(Pateclizumab)Related Search:

Vesencumab Benufutamab Bectumomab Research Grade Vandortuzumab (DHJ76001) Mavezelimab

Ivonescimab Bleselumab Vepalimomab Atoltivimab Lirentelimab

1of2

Pateclizumab Research Grade Pateclizumab Pateclizumab (anti-TNFb) 1202526-59-7